AMRX - Amneal Pharmaceuticals Non-GAAP EPS of $0.12 misses by $0.01 revenue of $497.63M misses by $4.66M
Amneal Pharmaceuticals press release (NYSE:AMRX): Q1 Non-GAAP EPS of $0.12 misses by $0.01. Revenue of $497.63M (+0.9% Y/Y) misses by $4.66M. FY22 Guidance: Net revenue of $2.15B-$2.25B vs consensus of $2.19B; Adj EPS of $0.80-$0.85 vs consensus of $0.84
For further details see:
Amneal Pharmaceuticals Non-GAAP EPS of $0.12 misses by $0.01, revenue of $497.63M misses by $4.66M